| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD012695 |
| P932 | PMC publication ID | 6481882 |
| P50 | author | Christian Gluud | Q26265142 |
| P2093 | author name string | Christian Gluud | |
| Lise Lotte Gluud | |||
| Anders Borch | |||
| Chastine Kolster | |||
| P2860 | cites work | Vaccines for preventing hepatitis B in health-care workers | Q24245861 |
| Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods | Q24288962 | ||
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Booster dose vaccination for preventing hepatitis B | Q26471510 | ||
| A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints | Q29614902 | ||
| The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide | Q29616215 | ||
| Requirements for global elimination of hepatitis B: a modelling study | Q30061950 | ||
| Imputation methods for missing outcome data in meta-analysis of clinical trials | Q31159481 | ||
| Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches | Q33201947 | ||
| Hepatitis B vaccination and the risk of multiple sclerosis | Q33932957 | ||
| Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment | Q33948133 | ||
| Chronic hepatitis B. | Q34002160 | ||
| Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening | Q34677180 | ||
| Update on viral hepatitis: 2007. | Q34769655 | ||
| Physicians infrequently adhere to hepatitis vaccination guidelines for chronic liver disease | Q34907938 | ||
| Comparison of immunogenicity and safety of four doses and four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: a randomized, controlled trial | Q35050640 | ||
| Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial | Q35063655 | ||
| Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy | Q35072187 | ||
| Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety | Q35535861 | ||
| Preventing and treating hepatitis B infection | Q35940524 | ||
| Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs | Q36191001 | ||
| Improving hepatitis B vaccine efficacy in end-stage renal diseases patients and role of adjuvants | Q36279736 | ||
| A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing | Q36711264 | ||
| Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases | Q37303528 | ||
| Diagnosis of hepatitis B virus infection through serological and virological markers. | Q37345962 | ||
| Update on viral hepatitis: 2008. | Q37455996 | ||
| Does increased hepatitis B vaccination dose lead to a better immune response in HIV-infected patients than standard dose vaccination: a meta-analysis? | Q38087214 | ||
| Developing an evidence-based guideline for the management of exposure to hepatitis B at a Victorian tertiary hospital | Q38148796 | ||
| Chronic hepatitis B virus infection | Q38165264 | ||
| The issue of mandatory vaccination for healthcare workers in Europe | Q38172273 | ||
| Immunotherapeutic interventions in chronic hepatitis B virus infection: a review | Q38205699 | ||
| Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs | Q38446397 | ||
| The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases | Q38555725 | ||
| Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine | Q39392849 | ||
| Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness | Q39488403 | ||
| Risks of chronicity following acute hepatitis B virus infection: a review | Q40552593 | ||
| Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine. | Q42209361 | ||
| Clinical and virological characteristics associated with severe acute hepatitis B. | Q42210385 | ||
| WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs | Q42235672 | ||
| Clinical presentation and disease phases of chronic hepatitis B using conventional versus modified ALT criteria in Asian Americans | Q42237599 | ||
| Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka | Q42287279 | ||
| A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report | Q44266138 | ||
| Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare | Q44564223 | ||
| Immune response and immunologic memory in medical personnel vaccinated with hepatitis B vaccine. | Q45860008 | ||
| Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials | Q47192223 | ||
| Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. | Q52003087 | ||
| Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults | Q57793040 | ||
| P433 | issue | 6 | |
| P577 | publication date | 2017-06-22 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Vaccines for preventing hepatitis B in healthcare workers (an updated protocol) | |
| P478 | volume | 2017 |
| Q58417808 | Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis | cites work | P2860 |
Search more.